Tag: 2022

The speech made by Caroline Lucas, the Green Party MP for Brighton Pavilion, in the House of Commons on 31 October 2022.

It is a pleasure to follow the important speech by the right hon. Member for North Thanet (Sir Roger Gale), with which I agreed. As I said on Second Reading, this is a flawed Bill; it is unclear and it is not robust, and legal experts have said that it is staggeringly imprecise. Nothing that has happened since Second Reading has caused me to change my mind, so I have tabled a number of amendments, and welcome the opportunity to speak to them, starting with amendments 1 and 2, which would remove animals from the Bill’s scope and title. For the record, it is my intention to press amendment 1 to a vote.

As I say, amendment 1 would remove animals from the scope of the Bill, but the intention is not, as the right hon. Member for Camborne and Redruth (George Eustice) suggested, to kick the can down the road; I genuinely believe that we need more time to look more carefully at what kind of regulatory framework we need, so that we can make the most of potential benefits, but also safeguard ourselves against risk. I acknowledge that there may well be potential benefits to the legislation, but I hope that others will acknowledge that there may well be serious risks, and I do not think that the work has been done to get the balance right in the Bill. We need more safeguards that are commensurate with the risks. That is why—for the moment, at least—we should remove animals from its scope. If the Government wish to legislate on gene editing of animals, they need to give much more thought to defining the circumstances in which that is acceptable, and to provide much more detail on how it will be regulated.

I recognise that clauses 10 to 15 are an attempt to prevent the significant risks that are associated with precision breeding, but I do not think that those measures are sufficient. When we debated the animal sentience legislation, the Government were prepared to accept that there should be a mechanism, via the animal welfare hub, through which the impact of animal sentience legislation could be properly considered by independent experts with the relevant skills. There is an urgent need for something similar that allows us to judge whether genetic engineering will be harmful to animals, how it can be better regulated, and how that can be done transparently. The model in clause 11, however, gives the person applying for authorisation and the Secretary of State far too much authority and responsibility, and the proposed animal welfare advisory body is given only a weak, secondary, advisory role. I worry that that suggests that welfare considerations will carry very limited weight in decision making.

It is also of concern that, under the Bill, the full regulatory system is supposed to be set through secondary legislation. That vastly reduces the scope for vital parliamentary scrutiny on issues of animal welfare and gene editing.

The claims made for gene editing mainly focus on increasing productivity and disease resistance. The Government argue that gene editing is simply an extension of traditional breeding, such as selective breeding, but is more precise and efficient. I assume that is intended to be reassuring, but over the last 50 years selective breeding has itself caused substantial health and welfare problems in most of the main farmed species. We have already heard about the concerns about broiler chickens who have been bred to grow so quickly that many suffer from leg disorders, while others succumb to heart disease. Hens have been bred to lay over 300 eggs a year. They have to draw on their own bone calcium to produce egg shells. This results in osteoporosis, leaving them susceptible to bone fracture. A cow producing milk for her calf would normally produce just over 1,000 litres in her 10-month lactation. Many of today’s dairy cows have been bred to produce 10,000, or even 11,000 or 12,000 litres of milk a year. That contributes, unsurprisingly, to many suffering from lameness, mastitis and reproductive disorders, and the animals live with those welfare problems for a substantial part of their lives.

Gene editing for even faster growth and higher yields would exacerbate the suffering caused by selective breeding. I believe it would be unethical to permit it for increased productivity, and it simply should not be necessary for disease resistance. The proper way to reduce diseases that are generated by keeping animals in poor conditions is to move instead to health-oriented farming systems, in which good health is inherent in the farming methods. Indeed, gene editing could lead to animals being kept in even more crowded and stressful conditions, as they would be resistant to the disease risks that are inherent in those conditions.

I cannot be the only Member who has been lobbied hard to remove animals from the Bill’s scope. I urge the Government to listen to the public and look again at this. They should return the legislation on this subject only once they have given much more detailed consideration to the issues that I have raised. Another of those issues is that nobody involved in drafting this legislation could, I imagine, have honestly envisaged it applying to, for example, domestic cats and dogs. Yet, without clarification, that is exactly what the current drafting could result in.

Our constituents want to be confident that there is consistency in the Government’s ambition for improving animal welfare. They want to know that gene editing cannot be used as some kind of techno-fix and that it will not entrench intensive farming, with its inherent environmental and animal welfare shortcomings. If my amendments are a step too far, I would urge Ministers, as a form of compromise, to bring forward an amendment of their own in the other place that will at the very least limit the scope much more explicitly to farmed animals. In the meantime, my amendments 1 and 2 would remove animals from the scope of the Bill.

Let me move on briefly to a few other amendments in my name. New clause 7 is about informing consumers about what they are buying. It would require the Secretary of State to make regulations on the labelling of this new class of GMO and to do so in consultation with key named stakeholders. Clear labelling is something that we know consumers want. The Food Standards Agency found that:

“Consumers wanted transparent labelling…if genome edited foods reach the UK market.”

My new clause does not prescribe what form that labelling should take; the groups and organisations that it lists for consultation are much better placed to determine that. They include the FSA, food producers, retailers, consumers and anyone else the Government think appropriate. In other words, it would allow for co-operative, sensible, well-informed approaches. I hope Members will back new clause 7 on that basis. Finally, labelling—in either the form set out in my clause or some other form—could represent a step towards resolving the differences with the devolved Governments, which we have already heard about, for whom, for example, alignment with EU standards is a major priority and a current source of disagreement with Westminster.

Amendments 6, 7, 8, 9 and 10 are a group designed to ensure that regulation is sufficiently robust when it comes to authorising activities involving so-called precision-bred organisms. They seek to convert the powers afforded to the Secretary of State into requirements. In addition, amendment 8, alongside amendment 7, would require obligations relating to supply chain traceability. Without amendment 7, the Bill fails to mandate any such traceability for the new category of precision-bred organisms.

That would be inconsistent with the current long-standing requirement for mandatory traceability for GMOs and would create significant trade barriers for organic businesses in the UK wanting to export products to, for example, the EU or Northern Ireland. The UK organic sector is worth £3 billion, so it makes no economic sense not to amend the Bill and ensure mandatory supply chain traceability. Traceability of genetically engineered organisms is also essential to support recall in the event that novel allergens or toxins, or other safety issues emerge after release.

I believe the Bill is badly conceived and badly drafted. My amendments are all designed with one of two things in mind: to bring either clarity or robustness to the regulatory framework for precision-bred organisms. It is with that intention that I lent my name to a number of other amendments, on behalf of the official Opposition in particular. I hope that they might support mine in the same spirit.